Innova Biosciences awarded EU grant to develop cancer biomarker discovery platform


18-02-2009

Innova Biosciences Ltd (Cambridge, UK), a leader in the field of bioconjugation, has been awarded €455,000 of a €3,000,000 European grant.

 Please download the press release below:

 

Babraham Bioscience Technologies Ltd (BBT) is responsible for the commercial development of the Babraham Research Campus. The Babraham Research Campus is distinct in its co-location of bioscience companies with the Babraham Institute, a world-renowned research organisation. The Campus provides companies laboratory and office space together with access to outstanding scientific facilities in an ideal geographical location at the core of the Cambridge cluster.

Babraham Research Campus Ltd.